Matches in SemOpenAlex for { <https://semopenalex.org/work/W2993295717> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2993295717 endingPage "E397" @default.
- W2993295717 startingPage "E397" @default.
- W2993295717 abstract "The aim of this study was to determine the efficacy, late adverse events, and 10-year survival outcome of 5-fluorouracil administered continuously for 120 h combined with cisplatin via a superficial temporal artery in patients with advanced T-stage nasopharyngeal carcinoma (NPC). Forty-five patients with histologically confirmed advanced T-stage NPC were eligible for inclusion in this clinical trial. The patients received induction chemotherapy consisting of cisplatin (20 mg/m2/d for 1–5 d) and 5-fluorouracil, administered continuously for 120 h at different dose gradients(200-500mg/m2/d) via a superficial temporal artery. Following two cycles of induction chemotherapy, radical radiotherapy was commenced. We assessed the efficacy, survival, toxicity, and quality of life of patients following treatment, especially in terms of oral mucositis and radiation-induced brain damage. The overall response (complete response + partial response) rates following induction chemotherapy in the primary mass and lymph nodes were 100% and 100%, respectively. The maximum tolerated dose(MTD) of 5-Fluorouracil was 450mg/m2,we also determined the optimal dose was 400mg/m2 according to the response, toxicities and survival. All 45 (100%) patients achieved down-staging of T-category after induction chemotherapy. No late neurological toxicities, such as brain stem injury, temporal lobe necrosis, and spinal cord injury, were observed. The 5-year and 10-year overall survival (OS) rates were 79% and 64.7%, with a median OS of 128 months. 5-Fluorouracil continuous infusion combined with cisplatin via a superficial temporal artery showed promising survival and low toxicities in patients with advanced T-stage NPC." @default.
- W2993295717 created "2019-12-13" @default.
- W2993295717 creator A5016729352 @default.
- W2993295717 creator A5029359712 @default.
- W2993295717 creator A5032044745 @default.
- W2993295717 creator A5041032488 @default.
- W2993295717 creator A5086578270 @default.
- W2993295717 creator A5088721580 @default.
- W2993295717 date "2019-09-01" @default.
- W2993295717 modified "2023-10-16" @default.
- W2993295717 title "5-Fluorouracil Combined with Cisplatin Via Arterial Induction for Advanced T-Stage Nasopharyngeal Carcinoma: A 10-Year Outcome Study" @default.
- W2993295717 doi "https://doi.org/10.1016/j.ijrobp.2019.06.1577" @default.
- W2993295717 hasPublicationYear "2019" @default.
- W2993295717 type Work @default.
- W2993295717 sameAs 2993295717 @default.
- W2993295717 citedByCount "0" @default.
- W2993295717 crossrefType "journal-article" @default.
- W2993295717 hasAuthorship W2993295717A5016729352 @default.
- W2993295717 hasAuthorship W2993295717A5029359712 @default.
- W2993295717 hasAuthorship W2993295717A5032044745 @default.
- W2993295717 hasAuthorship W2993295717A5041032488 @default.
- W2993295717 hasAuthorship W2993295717A5086578270 @default.
- W2993295717 hasAuthorship W2993295717A5088721580 @default.
- W2993295717 hasConcept C126322002 @default.
- W2993295717 hasConcept C141071460 @default.
- W2993295717 hasConcept C143998085 @default.
- W2993295717 hasConcept C146357865 @default.
- W2993295717 hasConcept C151730666 @default.
- W2993295717 hasConcept C2776283816 @default.
- W2993295717 hasConcept C2776611710 @default.
- W2993295717 hasConcept C2776694085 @default.
- W2993295717 hasConcept C2778239845 @default.
- W2993295717 hasConcept C2778496288 @default.
- W2993295717 hasConcept C2778997737 @default.
- W2993295717 hasConcept C2780456651 @default.
- W2993295717 hasConcept C509974204 @default.
- W2993295717 hasConcept C71924100 @default.
- W2993295717 hasConcept C86803240 @default.
- W2993295717 hasConcept C90924648 @default.
- W2993295717 hasConceptScore W2993295717C126322002 @default.
- W2993295717 hasConceptScore W2993295717C141071460 @default.
- W2993295717 hasConceptScore W2993295717C143998085 @default.
- W2993295717 hasConceptScore W2993295717C146357865 @default.
- W2993295717 hasConceptScore W2993295717C151730666 @default.
- W2993295717 hasConceptScore W2993295717C2776283816 @default.
- W2993295717 hasConceptScore W2993295717C2776611710 @default.
- W2993295717 hasConceptScore W2993295717C2776694085 @default.
- W2993295717 hasConceptScore W2993295717C2778239845 @default.
- W2993295717 hasConceptScore W2993295717C2778496288 @default.
- W2993295717 hasConceptScore W2993295717C2778997737 @default.
- W2993295717 hasConceptScore W2993295717C2780456651 @default.
- W2993295717 hasConceptScore W2993295717C509974204 @default.
- W2993295717 hasConceptScore W2993295717C71924100 @default.
- W2993295717 hasConceptScore W2993295717C86803240 @default.
- W2993295717 hasConceptScore W2993295717C90924648 @default.
- W2993295717 hasIssue "1" @default.
- W2993295717 hasLocation W29932957171 @default.
- W2993295717 hasOpenAccess W2993295717 @default.
- W2993295717 hasPrimaryLocation W29932957171 @default.
- W2993295717 hasRelatedWork W2037357991 @default.
- W2993295717 hasRelatedWork W2367534243 @default.
- W2993295717 hasRelatedWork W2377959084 @default.
- W2993295717 hasRelatedWork W2381773013 @default.
- W2993295717 hasRelatedWork W2385197461 @default.
- W2993295717 hasRelatedWork W2391206458 @default.
- W2993295717 hasRelatedWork W2392262560 @default.
- W2993295717 hasRelatedWork W2898369814 @default.
- W2993295717 hasRelatedWork W3030223433 @default.
- W2993295717 hasRelatedWork W933517682 @default.
- W2993295717 hasVolume "105" @default.
- W2993295717 isParatext "false" @default.
- W2993295717 isRetracted "false" @default.
- W2993295717 magId "2993295717" @default.
- W2993295717 workType "article" @default.